Amyris Welcomes Dr. Sunil Chandran Back as Chief Technology Officer to Drive Innovation in Renewable Biological Chemistry
[City, State] – September 2, 2025 – Amyris, Inc., a leader in the development and production of sustainable ingredients through synthetic biology, today announced the appointment of Dr. Sunil Chandran as its new Chief Technology Officer. This marks a significant return for Dr. Chandran, who previously held a key leadership role within the company, bringing with him extensive expertise in biological chemistry and a proven track record of innovation.
The strategic decision to bring Dr. Chandran back into the fold underscores Amyris’s commitment to meeting the rapidly escalating global demand for innovative and renewable biological chemistry solutions. As industries increasingly seek sustainable alternatives to petrochemical-derived products, Amyris is poised to lead the charge, and Dr. Chandran’s leadership is expected to be instrumental in accelerating this mission.
In his new capacity as CTO, Dr. Chandran will oversee Amyris’s robust research and development pipeline, focusing on further optimizing the company’s proprietary fermentation technology and expanding its portfolio of high-performance, bio-based ingredients. His deep understanding of microbial engineering and bioprocess development will be crucial in driving forward the next generation of Amyris’s groundbreaking products, which serve a wide array of markets including beauty, health, and wellness.
“We are absolutely thrilled to welcome Dr. Sunil Chandran back to the Amyris family as our Chief Technology Officer,” said [Insert Name and Title of CEO or relevant executive here]. “Sunil is a visionary scientist with an unparalleled depth of knowledge in synthetic biology and a profound understanding of our core technologies. His return at this pivotal moment will undoubtedly bolster our capacity to innovate and scale, enabling us to efficiently deliver on the increasing customer demand for truly sustainable and high-quality biological chemistry solutions. We are confident that his leadership will be a driving force in achieving our strategic growth objectives.”
Dr. Chandran’s prior contributions to Amyris were marked by significant advancements in strain engineering and fermentation processes, which were critical to the company’s early successes and its ability to bring novel bio-based ingredients to market. His return signals a renewed focus on technological excellence and operational efficiency as Amyris continues to solidify its position as a frontrunner in the bio-based economy.
“I am incredibly excited to rejoin Amyris and contribute to its mission of creating a more sustainable future through the power of biology,” stated Dr. Sunil Chandran. “The progress Amyris has made in recent years is truly inspiring, and I am eager to leverage my experience to help the company navigate its next phase of growth. The opportunity to work alongside such a talented team to address the critical need for renewable and innovative chemical solutions is a privilege. I am particularly enthusiastic about the prospect of further developing our technologies to meet the evolving needs of our customers and the planet.”
With a career dedicated to advancing the field of biotechnology, Dr. Chandran brings a wealth of experience and a forward-thinking approach to Amyris. His leadership is expected to catalyze further breakthroughs in the development of bio-fermented molecules, offering consumers and businesses alike more sustainable and effective choices across various product categories.
The appointment of Dr. Chandran as CTO is a testament to Amyris’s strategic vision and its unwavering commitment to scientific innovation and environmental responsibility. As the company continues to expand its reach and impact, his expertise will be invaluable in navigating the complexities of the bio-based market and delivering on its promise of a healthier, more sustainable world.
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
PR Newswire Environment published ‘Dr. Sunil Chandran Rejoins Amyris as Chief Technology Officer to Meet Growing Customer Demand for Innovative and Renewable Biological Chemistry’ at 2025-09-02 15:00. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.